Freestone Capital Holdings’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-48,624
| Closed | -$696K | – | 571 |
|
|
2022
Q1 | $696K | Buy |
48,624
+35,928
| +283% | +$514K | 0.03% | 294 |
|
|
2021
Q4 | $173K | Buy |
+12,696
| New | +$173K | 0.01% | 481 |
|
|
2021
Q3 | – | Sell |
-11,016
| Closed | -$185K | – | 439 |
|
|
2021
Q2 | $185K | Sell |
11,016
-3,467
| -24% | -$58.2K | 0.01% | 398 |
|
|
2021
Q1 | $264K | Sell |
14,483
-59,805
| -81% | -$1.09M | 0.01% | 343 |
|
|
2020
Q4 | $1.35M | Sell |
74,288
-76,407
| -51% | -$1.39M | 0.08% | 180 |
|
|
2020
Q3 | $2.69M | Sell |
150,695
-28,019
| -16% | -$500K | 0.18% | 122 |
|
|
2020
Q2 | $3.2K | Sell |
178,714
-16,101
| -8% | -$289 | 0.04% | 115 |
|
|
2020
Q1 | $2.96K | Buy |
194,815
+72,227
| +59% | +$1.1K | 0.06% | 107 |
|
|
2019
Q4 | $2.42K | Buy |
122,588
+3,594
| +3% | +$71 | 0.05% | 159 |
|
|
2019
Q3 | $2.05K | Buy |
118,994
+22,539
| +23% | +$388 | 0.05% | 172 |
|
|
2019
Q2 | $1.71K | Buy |
96,455
+16,642
| +21% | +$295 | 0.04% | 176 |
|
|
2019
Q1 | $1.63M | Buy |
79,813
+49,691
| +165% | +$1.01M | 0.1% | 169 |
|
|
2018
Q4 | $507K | Buy |
+30,122
| New | +$507K | 0.03% | 286 |
|